Pharmaceutical

Wane in Covid demand hurts Walgreens as profits drop to $118m

Walgreens Boots Alliance readjusted its 2023 outlook amidst mixed fiscal Q3 results.

Jun 27, 2023 - 20:00
Wane in Covid demand hurts Walgreens as profits drop to $118m
Walgreens Boots Alliance readjusted its 2023 outlook amidst mixed fiscal Q3 results.
Read the original article

Tags:

Previous Article

Rystiggo receives FDA approval, strengthening UCB’s myasthenia gravis portfolio

Next Article

EMA CHMP issues positive opinion for AstraZeneca’s Soliris

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: FDA declines to approve higher dose version of Regeneron eye drug; FDA warns wholesaler over counterfeit HIV pills

STAT+: Pharmalittle: FDA declines to approve higher dos...

Jun 28, 2023

MediLink and Roche partner on cancer drug development

MediLink and Roche partner on cancer drug development

Jan 3, 2024

STAT+: With savvy bets, a dynamic duo makes Eli Lilly one of pharma’s biggest success stories

STAT+: With savvy bets, a dynamic duo makes Eli Lilly o...

Jul 6, 2023